Massaccesi Luca, Balistreri Carmela Rita
Department of Biomedical Sciences for Health, Università degli Studi di Milano, Via Mangiagalli, 31, 20133 Milan, Italy.
Cellular and Molecular Biology and Clinical Pathology Laboratory, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, Corso Tukory 211, 90134 Palermo, Italy.
Antioxidants (Basel). 2022 Sep 7;11(9):1766. doi: 10.3390/antiox11091766.
Molecular biomarkers consent to apply individual decisions in the complex management of both acute or chronic diseases, and their identification constitutes a fundamental phase for achieving the important object to develop personalized therapies [...].
分子生物标志物有助于在急性或慢性疾病的复杂管理中做出个体化决策,其识别是实现开发个性化疗法这一重要目标的关键阶段。